Hydreight Technologies Closes Successful Convertible Debenture Offering
Hydreight Technologies Inc. has recently completed the closing of an oversubscribed private placement of unsecured convertible debentures. This significant offering, which totals C$11.5 million, marks a strategic move towards bolstering the company’s foundation as a leader in the digital healthcare space. The offering was facilitated by Canaccord Genuity Corp., alongside a syndicate of agents who played a crucial role in its success.
Details of the Debenture Offering
The offering comprised a total of 11,500 convertible debentures, each with a price of C$1,000 set at launch. Impressively, this includes an additional 1,500 debentures that were made available through the full exercise of the over-allotment option by the agents. These debentures, which are secured by an indenture with Odyssey Trust Company, are set to mature in four years, specifically on September 4, 2028, and carry a competitive interest rate of 9.0% per annum.
Understanding the Conversion Features
One key feature of these convertible debentures is their potential to convert into common shares of Hydreight at the holder's discretion, at an attractive conversion price of C$4.06 per share. Interest payments are planned to be made semi-annually, with the first payment expected at the end of December. An interesting aspect of the debentures is the company’s right to enforce conversion if the trading price of its common shares exceeds C$5.08 over a specified period.
Leadership Insight on Business Growth
Shane Madden, the CEO of Hydreight, expressed optimism following the closure of this offering. He noted in the company’s recent financial disclosures that Hydreight has achieved profitability. This funding is poised to facilitate strategic growth, which aligns with the company’s vision for the future. Madden highlighted the importance of the support from investors, clients, and the dedicated team as essential to achieving the company’s goals.
Compensation for the Agents
As part of the agreement, the agents facilitating this offering received compensation totaling C$690,000. This amount includes a cash commission and a number of warrants, which are options to acquire common shares in the future at a predetermined price.
Utilization of Offering Proceeds
The net funds sourced from this offering are earmarked for corporate growth and working capital purposes, underscoring Hydreight’s commitment to advancing its operational capabilities. The company is set to finalize compliance with the regulations set forth by the TSX Venture Exchange.
About Hydreight Technologies Inc.
Hydreight Technologies is at the forefront of revolutionizing healthcare accessibility through a comprehensive mobile clinic network. The company operates a platform that supports over 2,500 nurses and 100 doctors across the nation. This network not only enhances patient care through convenient services delivered at home, but also empowers healthcare professionals with a suite of integrated tools for managing patient interactions, ensuring compliance, and streamlining operations.
Future Prospects
As Hydreight ventures into the coming years, it will continue to focus on innovation and expanding its services. The successful closing of this convertible debenture offering lays the groundwork for potential new initiatives and enhancements in patient care solutions across the United States.
Frequently Asked Questions
What is Hydreight Technologies Inc.?
Hydreight Technologies Inc. is a company dedicated to transforming digital healthcare services through a robust mobile clinic network that connects healthcare professionals and patients directly.
How much was raised in the convertible debenture offering?
The company successfully raised C$11.5 million in its convertible debenture offering, thanks to high investor interest.
What are the terms of the debenture?
The debentures carry a 9.0% interest rate and are convertible into common shares at C$4.06 per share, maturing in 2028.
What will the proceeds be used for?
The proceeds from the offering will be utilized for general corporate purposes and working capital, supporting Hydreight's ongoing growth strategy.
Who can invest in the convertible debentures?
The offering is primarily targeted at accredited investors, in accordance with regulations governing such securities in Canada.
